Galectin Therapeutics (GALT) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.45% |
| Dec 31, 2025 | 8.17% |
| Sep 30, 2025 | 18.75% |
| Jun 30, 2025 | 19.51% |
| Mar 31, 2025 | 29.72% |
| Sep 30, 2024 | 11.67% |
| Jun 30, 2024 | 13.23% |
| Mar 31, 2024 | -27.57% |
| Dec 31, 2023 | -25.47% |
| Sep 30, 2023 | -14.97% |
| Jun 30, 2023 | -11.35% |
| Mar 31, 2023 | -34.87% |
| Sep 30, 2022 | -17.87% |
| Jun 30, 2022 | -21.51% |
| Mar 31, 2022 | -18.29% |
| Sep 30, 2021 | -20.62% |
| Jun 30, 2021 | -14.23% |
| Mar 31, 2021 | -0.15% |
| Dec 31, 2020 | -2.41% |
| Sep 30, 2020 | -8.84% |
| Jun 30, 2020 | -9.11% |
| Mar 31, 2020 | -8.10% |
| Dec 31, 2019 | -10.27% |
| Sep 30, 2019 | -10.04% |
| Jun 30, 2019 | -8.62% |
| Mar 31, 2019 | 28.22% |
| Dec 31, 2018 | 4.68% |
| Sep 30, 2018 | -0.85% |
| Jun 30, 2018 | -15.54% |
| Mar 31, 2018 | 10.69% |
| Dec 31, 2017 | 20.08% |
| Sep 30, 2017 | 8.85% |
| Jun 30, 2017 | 7.02% |
| Mar 31, 2017 | -1.65% |
| Dec 31, 2016 | -29.35% |
| Sep 30, 2016 | -21.97% |
| Jun 30, 2016 | -22.96% |
| Mar 31, 2016 | -24.28% |
| Dec 31, 2015 | -41.64% |
| Sep 30, 2015 | -49.93% |
| Jun 30, 2015 | -55.89% |